Literature DB >> 24606042

Helicobacter pylori infection: A brief overview on alternative natural treatments to conventional therapy.

Paula Parreira1, M Fátima Duarte1, Celso A Reis2,3,4, M Cristina L Martins4,5.   

Abstract

Helicobacter pylori is a human gastric pathogen considered as the etiologic agent of several gastric disorders, that may range from chronic gastritis to more severe outcomes, including gastric cancer. The current therapeutic scheme relies on the combination of several pharmacological substances, namely antibiotics and proton pump inhibitors. However, the cure rates obtained have been declining over the years, mostly due to bacterial resistance to antibiotics. In this context, the use of non-antibiotic substances is of the utmost importance regarding H. pylori eradication. In this review, we present different classes of compounds obtained from natural sources that have shown to present anti-H. pylori potential; we briefly highlight their possible use in the context of developing new therapeutic approaches.

Entities:  

Keywords:  Bioactive compounds; bioengineering; gastric cancer; new therapies; phytotherapy

Mesh:

Substances:

Year:  2014        PMID: 24606042     DOI: 10.3109/1040841X.2014.892055

Source DB:  PubMed          Journal:  Crit Rev Microbiol        ISSN: 1040-841X            Impact factor:   7.624


  6 in total

1.  Influence of In Vitro Gastric Digestion of Olive Leaf Extracts on Their Bioactive Properties against H. pylori.

Authors:  Marisol Villalva; Jose Manuel Silvan; Esperanza Guerrero-Hurtado; Alba Gutierrez-Docio; Joaquín Navarro Del Hierro; Teresa Alarcón-Cavero; Marin Prodanov; Diana Martin; Adolfo J Martinez-Rodriguez
Journal:  Foods       Date:  2022-06-22

2.  Preparation, urease inhibition mechanisms, and anti-Helicobacter pylori activities of hesperetin-7-rhamnoglucoside.

Authors:  Mohamed Sharaf; Muhammad Arif; Hamed I Hamouda; Sohaib Khan; Mohnad Abdalla; Samah Shabana; Hussein E Rozan; Tehsin Ullah Khan; Zhe Chi; Chenguang Liu
Journal:  Curr Res Microb Sci       Date:  2021-12-29

3.  Antimicrobial Effect of a Proteolytic Enzyme From the Fruits of Solanum granuloso-leprosum (Dunal) Against Helicobacter pylori.

Authors:  Ángel Gabriel Salinas Ibáñez; Diego Vallés; Mauricio Adaro; Sonia Barberis; Alba E Vega
Journal:  Front Nutr       Date:  2021-12-16

4.  Anti-Helicobacter pylori Compounds from Oliveria decumbens Vent. through Urease Inhibitory In-vitro and In-silico Studies.

Authors:  Mahdieh Eftekhari; Mohammad Reza Shams Ardekani; Mohsen Amin; Mahboubeh Mansourian; Mina Saeedi; Tahmineh Akbarzadeh; Mahnaz Khanavi
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

5.  Asclepain cI, a proteolytic enzyme from Asclepias curassavica L., a south American plant, against Helicobacter pylori.

Authors:  Ángel Gabriel Salinas Ibáñez; Anabella L Origone; Constanza S Liggieri; Sonia E Barberis; Alba E Vega
Journal:  Front Microbiol       Date:  2022-08-18       Impact factor: 6.064

6.  Surface Grafted MSI-78A Antimicrobial Peptide has High Potential for Gastric Infection Management.

Authors:  Paula Parreira; Claudia Monteiro; Vanessa Graça; Joana Gomes; Sílvia Maia; Paula Gomes; Inês C Gonçalves; M Cristina L Martins
Journal:  Sci Rep       Date:  2019-12-03       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.